Pain Therapeutics (PTIE) Reports Commencement of Phase II Study in Alzheimer’s Disease
Tweet Send to a Friend
Pain Therapeutics, Inc. (NASDAQ: PTIE) announced today the initiation of a Phase II study to evaluate PTI-125 as a potential ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
